Frontlight ResearchEarly access
Epilepsy trials in China
31 of 45 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleA Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
- Where
- Nantong
- Age
- 1 year to 14 years
- People
- 30
- Run by
- Affiliated Hospital of Nantong University
See details and how to joinNCT06967012 - No phaseNot yet taking people in ChinaLong Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE
- Where
- Xi'an
- Age
- 18 years to 65 years
- People
- 100
- Run by
- Xijing Hospital
See details and how to joinNCT06832813 - No phaseTaking peoplePercutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale(PREDICT-PFO Trial)
- Where
- Chengdu
- Age
- 18 years to 60 years
- People
- 180
- Run by
- Sichuan University
See details and how to joinNCT06863350 - No phaseTaking peopleEvaluating Modulation Effects of Temporal Interference Using SEEG
- Where
- Beijing
- Age
- 14 years to 65 years
- People
- 20
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06663969 - No phaseTaking peopleEvaluating Modulation Effects of Burst Stimulation Patterns Using SEEG
- Where
- Beijing
- Age
- 14 years to 65 years
- People
- 20
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06667232 - Early phase 1Taking peopleSirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
- Where
- Beijing
- Age
- 18 years to 60 years
- People
- 15
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06719791